DEXTRAN SULFATE MICROPARTICLES ENCAPSULATING ISONIAZID AND/OR RIFABUTIN AS CARRIERS FOR PULMONARY TUBERCULOSIS THERAPY

被引：0

作者：

Musacchio, Flavia

Grenha, Ana

机构：

[1] Univ Algarve, Fac Sci & Technol, Ctr Biomed Res CBMR, P-8005139 Faro, Portugal

[2] Univ Algarve, Ctr Marine Sci CCMar, P-8005139 Faro, Portugal

来源：

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2017年 / 30卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：A20 / A21

页数：2

共 50 条

[41] OTOTOXICITY FROM INTERMITTENT STREPTOMYCIN SULFATE THERAPY OF PULMONARY TUBERCULOSIS - A STUDY OF 100 PATIENTS TREATED 8 MONTHS
CLINE, HL
HOUSEWORTH, JH
PITTS, FW
AMA ARCHIVES OF OTOLARYNGOLOGY, 1954, 59 (01): : 100 - 103
[42] Implementation of isoniazid preventive therapy among children living with diagnosed pulmonary tuberculosis patients: A mixed methods study from Mumbai, India
Sreevidya, P. A.
Acharya, Shrikala
Raul, Mayuri Umesh
Prakash, Aparna
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2025, 30 (02) : 93 - 98
[43] 6-MONTHS ISONIAZID-RIFAMPIN THERAPY FOR PULMONARY TUBERCULOSIS - REPORT OF A "UNITED-STATES-PUBLIC-HEALTH-SERVICE COOPERATIVE TRIAL
SNIDER, DE
LONG, MW
CROSS, FS
FARER, LS
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 129 (04): : 573 - 579
[44] CONTROL STUDY OF COMPARATIVE EFFICACY OF ISONIAZID, STREPTOMYCIN-ISONIAZID, AND STREPTOMYCIN-PARA-AMINOSALICYLIC ACID IN PULMONARY TUBERCULOSIS THERAPY .1. REPORT OF 12-WEEK OBSERVATIONS ON 526 PATIENTS
MOUNT, FW
FEREBEE, SH
AMERICAN REVIEW OF TUBERCULOSIS, 1952, 66 (05): : 632 - 635
[45] Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis
Park, Seung-Kyu
Kim, Jin-Hee
Kang, Hyungseok
Cho, Jeong Su
Smego, Raymond A., Jr.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (02) : 170 - 175
[46] Effect of isoniazid preventive therapy on pulmonary tuberculosis activity in people living with HIV/AIDS at Wangaya hospital in Denpasar, Bali, Indonesia: A prospective cohort study
Suryana, Ketut
Suharsono, Hamong
Antara, Jarwa
Rai, Ida Bagus Ngurah
BALI MEDICAL JOURNAL, 2020, 9 (01) : 219 - 223
[47] 6 MONTHS RIFAMPIN-ISONIAZID (RIF-INH) THERAPY OF PULMONARY TUBERCULOSIS - PRELIMINARY-REPORT OF A UNITED-STATES PHS COOPERATIVE TRIAL
LONG, MW
SNIDER, DE
FARER, LS
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1979, 119 (04): : 405 - 405
[48] Adherence to Isoniazid Preventive Therapy among Under-Five Children in Contact with Adult Bacteriologically Confirmed Pulmonary Tuberculosis Patients: A Mixed-Method Study
Seid, Getachew
Tsedalu, Tsegaye
Ayele, Marta
INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2020, 2020
[49] CONTROL STUDY OF COMPARATIVE EFFICACY OF ISONIAZID, STREPTOMYCIN-ISONIAZID, AND STREPTOMYCIN PARA-AMINOSALICYLIC ACID IN PULMONARY TUBERCULOSIS THERAPY .4. REPORT ON 40 WEEK OBSERVATIONS ON 583 PATIENTS WITH STREPTOMYCIN-SUSCEPTIBLE INFECTIONS
MOUNT, FW
JENKINS, BE
FEREBEE, SH
AMERICAN REVIEW OF TUBERCULOSIS, 1953, 68 (02): : 264 - 269
[50] CONTROL STUDY OF COMPARATIVE EFFICACY OF ISONIAZID, STREPTOMYCIN-ISONIAZID, AND STREPTOMYCIN-PARA-AMINOSALICYCLIC ACID IN PULMONARY TUBERCULOSIS THERAPY .2. REPORT ON 20-WEEK OBSERVATIONS ON 390 PATIENTS WITH STREPTOMYCIN-SUSCEPTIBLE INFECTIONS
MOUNT, FW
FEREBEE, SH
AMERICAN REVIEW OF TUBERCULOSIS, 1953, 67 (01): : 108 - 113

← 1 2 3 4 5 →